Quantcast Corporate Use Of Blogging - Johnson & Johnson And The Lawsuit
Search by tag or site Login to my blog ? Start my own blog














TheMoneyBlogs
Home
About
Create your own blog
Contact us
Vote for this blog!

BioHealth Investor

BioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network.

Corporate Use Of Blogging - Johnson & Johnson And The Lawsuit

Posted on 08/17/2007 06:06:57 | Link | Post Comment
by Mark S. Senak
Eye On FDA



As noted here previously, the Johnson and Johnson (JNJ) blog launched by the company - JNJ BTW - is an unusual and bold experiment in new media and pharma.

Since its launch, the blog has covered a range of topics, trying I think to find it's voice. For example, the other day, they had a posting about the now famous Oscar the Cat - from the article in the New England Journal of Medicine about a cat with an uncanny ability to predict the deaths of nursing home residents. It is an interesting story, but it has nothing to do with J&J. That's ok. It is a blog, after all, and the nature of a blog is self-expression.

But the real utility of a corporate blog came in this circumstance comes into full light this week. J&J has filed a lawsuit against the American Red Cross. If you are a casual observer to the news, you may instantly form a negative opinion about that from a headline - a pharmaceutical company suing a charity.

But J&J has used the blog to put out their point of view. The past week has seen several postings on their own blog that explains the basis for the suit:

Just to be Clear - August 10

And the Coverage Continues - Also August 10

You're Doing What? - August 9

Whatever you feel about the merits, it is very interesting from a communications point of view. It is the type of story that many bloggers were talking about: John Mack at Pharmablogosphere - Ed Silverman at Pharmalot - Peter Rost at Brandweek NrX - Seth Godin at Seth Godin's Blog - GruntDoc - and the list goes on. So, true to their own reason for starting the blog - "By The Way... Everyone else is talking about our company, so why can’t we?" - the company is talking about the company. In other words, the conversation is not happening without them - they are in it.

And that is the beauty of the corporate blog.




Eye On FDA is a regular contributor to BioHealth Investor
_____________
Stock Quote or
Examples
ATM Wallstreet - Mon Oct 06, 2008 03:39PM
Made several great trades today. Traded the QID, QQ [read more]
ATM Wallstreet - Sat Oct 04, 2008 10:41PM
When I first started Day Trading I traded anything that [read more]
Morpheus Trading - Thu Oct 02, 2008 08:58AM
NOTE: Please click on the charts below to enlarge them if [read more]

PREMIER SPONSORED LINKS

Most Visited Blogs | Most Popular Blogs | Most Recent Blogs | Contact Us | Terms and conditions | Privacy Policy

The columns, articles, message board posts and any other features provided on TheMoneyBlogs.com are provided for personal finance, education and investment information and are not to be construed as investment advice. Under no circumstances does the information in this content represent a recommendation to buy, sell or hold any security. The views and opinions expressed in an article or column are the author's own and not necessarily those of TheMoneyBlogs.com and there is no implied endorsement by TheMoneyBlogs.com of any advice or trading strategy. The analysts and employees or affiliates of TheMoneyBlogs.com may hold positions in the stocks or industries discussed here. Your use of this and all information contained on TheMoneyBlogs.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

Copyright © 2008 The Connors Group, Inc.